Kathryn A. Seely

2.1k total citations · 1 hit paper
20 papers, 1.6k citations indexed

About

Kathryn A. Seely is a scholar working on Pharmacology, Toxicology and Molecular Biology. According to data from OpenAlex, Kathryn A. Seely has authored 20 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 7 papers in Toxicology and 4 papers in Molecular Biology. Recurrent topics in Kathryn A. Seely's work include Cannabis and Cannabinoid Research (10 papers), Forensic Toxicology and Drug Analysis (7 papers) and Analytical chemistry methods development (2 papers). Kathryn A. Seely is often cited by papers focused on Cannabis and Cannabinoid Research (10 papers), Forensic Toxicology and Drug Analysis (7 papers) and Analytical chemistry methods development (2 papers). Kathryn A. Seely collaborates with scholars based in United States and Italy. Kathryn A. Seely's co-authors include Jeffery H. Moran, Paul L. Prather, Liana Fattore, Jeff Lapoint, Philip R. Mayeux, Neriman Gökden, Joseph H. Holthoff, Laura P. James, Lisa K. Brents and Anna Radomińska‐Pandya and has published in prestigious journals such as SHILAP Revista de lepidopterología, Analytical Chemistry and The FASEB Journal.

In The Last Decade

Kathryn A. Seely

18 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Spice drugs are more than harmless herbal blends: A review of the pharmacology and toxicology of synthetic cannabinoids

2012 358 citations Kathryn A. Seely, Jeff Lapoint et al. Progress in Neuro-Psychopharmacology and Biological Psychiatry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kathryn A. Seely United States	16	868	722	396	242	238	20	1.6k
John Ambre United States	18	435 0.5×	505 0.7×	462 1.2×	236 1.0×	106 0.4×	37	1.6k
W. Brooks Gentry United States	25	369 0.4×	254 0.4×	502 1.3×	553 2.3×	59 0.2×	51	2.1k
Farimah Beheshti Iran	31	261 0.3×	93 0.1×	233 0.6×	600 2.5×	20 0.1×	164	2.5k
John‐Michael Sauer United States	20	687 0.8×	61 0.1×	335 0.8×	308 1.3×	35 0.1×	44	1.9k
Jeffery H. Moran United States	26	1.8k 2.1×	1.7k 2.4×	744 1.9×	368 1.5×	555 2.3×	60	2.8k
Kazuta Oguri Japan	26	330 0.4×	170 0.2×	474 1.2×	670 2.8×	42 0.2×	112	2.3k
Hajime Yasuhara Japan	17	189 0.2×	224 0.3×	142 0.4×	425 1.8×	11 0.0×	135	1.7k
Dalaal M. Abdallah Egypt	22	144 0.2×	67 0.1×	216 0.5×	523 2.2×	7 0.0×	75	1.6k
Mihoko N. Nakashima Japan	16	203 0.2×	77 0.1×	127 0.3×	156 0.6×	28 0.1×	56	947
Siavash Parvardeh Iran	18	95 0.1×	181 0.3×	144 0.4×	247 1.0×	16 0.1×	50	1.3k

Countries citing papers authored by Kathryn A. Seely

Since Specialization

Citations

This map shows the geographic impact of Kathryn A. Seely's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn A. Seely with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn A. Seely more than expected).

Fields of papers citing papers by Kathryn A. Seely

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathryn A. Seely. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn A. Seely. The network helps show where Kathryn A. Seely may publish in the future.

Co-authorship network of co-authors of Kathryn A. Seely

This figure shows the co-authorship network connecting the top 25 collaborators of Kathryn A. Seely. A scholar is included among the top collaborators of Kathryn A. Seely based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathryn A. Seely. Kathryn A. Seely is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Surie, Diya, Allison C. Brown, Elizabeth Beshearse, et al.. (2021). Infectious period of SARS-CoV-2 in 17 nursing home residents — Arkansas, June–August 2020. Open Forum Infectious Diseases.

Matich, Eryn K., et al.. (2021). Association between pesticide exposure and colorectal cancer risk and incidence: A systematic review. Ecotoxicology and Environmental Safety. 219. 112327–112327. 50 indexed citations

Patton, Amy, Kathryn A. Seely, William E. Fantegrossi, et al.. (2018). Altered metabolism of synthetic cannabinoid JWH-018 by human cytochrome P450 2C9 and variants. Biochemical and Biophysical Research Communications. 498(3). 597–602. 23 indexed citations

Kubachka, Kevin M., Douglas T. Heitkemper, Sean D. Conklin, et al.. (2017). Multilaboratory Validation of First Action Method 2016.04 for Determination of Four Arsenic Species in Fruit Juice by High-Performance Liquid Chromatography–Inductively Coupled Plasma–Mass Spectrometry. Journal of AOAC International. 100(4). 1077–1085. 2 indexed citations

Pfannkoch, Edward A., et al.. (2015). A High Throughput Method for Measuring Polycyclic Aromatic Hydrocarbons in Seafood Using QuEChERS Extraction and SBSE. SHILAP Revista de lepidopterología. 2015. 1–8. 22 indexed citations

Patton, Amy, Kathryn A. Seely, Krishna C. Chimalakonda, et al.. (2013). Targeted Metabolomic Approach for Assessing Human Synthetic Cannabinoid Exposure and Pharmacology. Analytical Chemistry. 85(19). 9390–9399. 27 indexed citations

Seely, Kathryn A., Amy Patton, Cindy L. Moran, et al.. (2013). Forensic investigation of K2, Spice, and “bath salt” commercial preparations: A three-year study of new designer drug products containing synthetic cannabinoid, stimulant, and hallucinogenic compounds. Forensic Science International. 233(1-3). 416–422. 85 indexed citations

Patton, Amy, Kathryn A. Seely, Sharon Pulla, et al.. (2013). Quantitative Measurement of Acetyl Fentanyl and Acetyl Norfentanyl in Human Urine by LC-MS/MS. Analytical Chemistry. 86(3). 1760–1766. 42 indexed citations

Chimalakonda, Krishna C., Kathryn A. Seely, Stacie M. Bratton, et al.. (2012). Cytochrome P450-Mediated Oxidative Metabolism of Abused Synthetic Cannabinoids Found in K2/Spice: Identification of Novel Cannabinoid Receptor Ligands. Drug Metabolism and Disposition. 40(11). 2174–2184. 163 indexed citations

10.

Seely, Kathryn A., Lisa K. Brents, Lirit N. Franks, et al.. (2012). AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: Implications for opioid/cannabinoid interaction studies. Neuropharmacology. 63(5). 905–915. 82 indexed citations

11.

Koryakina, Yulia, Stacie M. Jones, Lawrence E. Cornett, et al.. (2012). Effects of the β‐agonist, isoprenaline, on the down‐regulation, functional responsiveness and trafficking of β₂‐adrenergic receptors with N‐terminal polymorphisms. Cell Biology International. 36(12). 1171–1183. 11 indexed citations

12.

Seely, Kathryn A., Jeff Lapoint, Jeffery H. Moran, & Liana Fattore. (2012). Spice drugs are more than harmless herbal blends: A review of the pharmacology and toxicology of synthetic cannabinoids. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 39(2). 234–243. 358 indexed citations breakdown →

13.

Seely, Kathryn A., Lisa K. Brents, Anna Radomińska‐Pandya, et al.. (2012). A Major Glucuronidated Metabolite of JWH-018 Is a Neutral Antagonist at CB1 Receptors. Chemical Research in Toxicology. 25(4). 825–827. 49 indexed citations

14.

Holthoff, Joseph H., Zhen Wang, Kathryn A. Seely, Neriman Gökden, & Philip R. Mayeux. (2011). Resveratrol improves renal microcirculation, protects the tubular epithelium, and prolongs survival in a mouse model of sepsis-induced acute kidney injury. Kidney International. 81(4). 370–378. 160 indexed citations

15.

Wang, Zhen, Joseph H. Holthoff, Kathryn A. Seely, et al.. (2011). Development of Oxidative Stress in the Peritubular Capillary Microenvironment Mediates Sepsis-Induced Renal Microcirculatory Failure and Acute Kidney Injury. American Journal Of Pathology. 180(2). 505–516. 133 indexed citations

16.

Brents, Lisa K., Fabricio Medina-Bolívar, Kathryn A. Seely, et al.. (2011). Natural prenylated resveratrol analogs arachidin-1 and -3 demonstrate improved glucuronidation profiles and have affinity for cannabinoid receptors. Xenobiotica. 42(2). 139–156. 44 indexed citations

17.

Seely, Kathryn A., Paul L. Prather, Laura P. James, & Jeffery H. Moran. (2011). Marijuana-based Drugs: Innovative Therapeutics or Designer Drugs of Abuse?. Molecular Interventions. 11(1). 36–51. 100 indexed citations

18.

Seely, Kathryn A., Joseph H. Holthoff, Samuel T. Burns, et al.. (2011). Hemodynamic changes in the kidney in a pediatric rat model of sepsis-induced acute kidney injury. American Journal of Physiology-Renal Physiology. 301(1). F209–F217. 81 indexed citations

19.

Seely, Kathryn A., et al.. (2007). The CB2 cannabinoid agonist AM‐1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset. Journal of Neurochemistry. 101(1). 87–98. 177 indexed citations

20.

Ronis, Martin J. J., et al.. (2006). Feeding of casein diets supplemented with blueberry or grape powder during development alters hepatic phase I and II metabolism in Sprague Dawley rats.. The FASEB Journal. 20(5).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact